Target intelligence / Profile preview

Protein S pseudogene (PROS2P)

Target: PROS2P
Molecular classification: Pseudogene

Overview

PROS2P (Protein S pseudogene) is a non-functional genomic sequence that shares high sequence identity (97%) with the functional PROS1 gene encoding Protein S, a vitamin K-dependent plasma protein involved in blood coagulation[2][4]. PROS2P lacks exon 1 and is thought to be nontranscribed and incapable of encoding a functional protein[2]. Its presence in the genome can interfere with accurate genetic diagnosis of Protein S deficiency, as sequence similarity may lead to inappropriate amplification of the pseudogene during molecular genetic assays[2][4]. Like other pseudogenes, PROS2P is classified as "junk DNA" and does not contribute to cellular function, disease, or therapy[4].

Other names: PROS2PProtein S pseudogenePROS1 pseudogene

Mechanism of action

None applicable; pseudogenes do not provide therapeutic mechanisms.

Biological functions

None; PROS2P does not produce functional RNA or protein and is thought to be nontranscribed

Disease associations

None; while its high homology to PROS1 complicates genetic analysis for Protein S deficiency diagnosis, PROS2P itself is not implicated in disease

Safety considerations

None inherent; however, improper targeting (or misdiagnosis due to confusing with PROS1) could impact genetic test accuracy

Biomarkers

None; though it complicates genetic diagnostics by confounding genetic sequencing analyses targeting PROS1, PROS2P itself has no biomarker role

Beyond the preview

Go deeper on Protein S pseudogene (PROS2P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Protein S pseudogene (PROS2P).

Explore the full profile